Form 4: Teladoc Health CFO Mala Murthy Reports Stock Transactions
SEC Form 4
Teladoc Health's CFO, Mala Murthy, reported the acquisition and disposal of company stock and derivative securities, including restricted stock units and performance stock units, according to a Form 4 filing with the SEC.
Summary
- Mala Murthy, the CFO of Teladoc Health, filed a Form 4 with the SEC detailing changes in her beneficial ownership of the company's stock.
- On February 28, 2025, Murthy acquired shares through the conversion of restricted stock units (RSUs) and performance stock units (PSUs).
- Specifically, 3,369 shares were acquired from RSUs granted on March 1, 2022, 2,044 shares from RSUs granted on June 1, 2022, 7,750 shares from RSUs granted on March 3, 2023, and 2,641 shares from PSUs earned on March 1, 2024.
- On March 3, 2025, Murthy disposed of 8,630 shares at a price of $9.684 per share to cover tax withholding obligations related to the vesting of RSUs and PSUs.
- Following these transactions, Murthy directly owns 99,962 shares of Teladoc Health common stock and holds derivative securities including 2,044 restricted stock units, 31,004 restricted stock units, and 10,567 performance stock units.
- On March 1, 2025, Murthy was granted 172,594 restricted stock units, vesting over time.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company executives as an indicator of management's confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 03/01/2022 | Reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 06/01/2022 | Reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2023 | Reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/01/2024 | Reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 02/28/2025 | Date of earliest transaction (conversion of RSUs and PSUs). |
| 03/01/2025 | Reporting person was granted 172,594 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2025 | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.